Hong Jae Chon
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 37
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 22
- Cancer Immunotherapy and Biomarkers 22
- Pancreatic and Hepatic Oncology Research 17
- Immunology top 5%
-
- Gastric Cancer Management and Outcomes 14
- Gallbladder and Bile Duct Disorders 9
- Cancer Research top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 28
-
- Cancer Research and Treatments 9
- Co-authors
- Chan KimHannah YangWon Suk LeeBeodeul KangSun Young RhaSo Jung KongJaekyung CheonHyun Cheol Chung
- Cited by
- HepatologyOncologyImmunology
- Partner nations
- South KoreaUnited StatesTaiwan
In The Last Decade
Hong Jae Chon
118 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Hepatology 497
- Oncology 1.7k
- Immunology 849
- Pulmonary and Respiratory Medicine 847
- Cancer Research 373
Countries citing papers authored by Hong Jae Chon
This map shows the geographic impact of Hong Jae Chon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Jae Chon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Jae Chon more than expected).
Fields of papers citing papers by Hong Jae Chon
This network shows the impact of papers produced by Hong Jae Chon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Jae Chon. The network helps show where Hong Jae Chon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong Jae Chon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 29 | |
| 8 | 2023 | 15 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 17 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 13 | |
| 15 | 2020 | 34 | |
| 16 | 2020 | 31 | |
| 17 | 2020 | 1 | |
| 18 | 2020 | 38 | |
| 19 | 2016 | 47 | |
| 20 | 2011 | 4 |
About Hong Jae Chon
Hong Jae Chon is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 127 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Colorectal Cancer Treatments and Studies (22 papers), Cancer Immunotherapy and Biomarkers (22 papers), Pancreatic and Hepatic Oncology Research (17 papers), Gastric Cancer Management and Outcomes (14 papers), Cancer Research and Treatments (9 papers) and Gallbladder and Bile Duct Disorders (9 papers). The work is most often cited by research in Hepatology (497 citations), Oncology (1.7k citations) and Immunology (849 citations). Hong Jae Chon has collaborated with scholars based in South Korea, United States and Taiwan. Frequent co-authors include Chan Kim, Hannah Yang, Won Suk Lee, Beodeul Kang, Sun Young Rha, So Jung Kong, Jaekyung Cheon, Hyun Cheol Chung, Joo Hoon Kim and Joong Bae Ahn.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.